Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 1039-1044, February 1, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Szolgay-Daniel, E.
Right arrow Articles by Acker, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Szolgay-Daniel, E.
Right arrow Articles by Acker, H.

Effects of Amiloride Treatment on U-118 MG and U-251 MG Human Glioma and HT-29 Human Colon Carcinoma Cells1

Erika Szolgay-Daniel2, Jörgen Carlsson, Karl Zierold, Georg Holtermann, Evelyne Dufau and Helmut Acker

Department of Radiation Sciences, Uppsala University, Box 535, S-751 21 Uppsala, Sweden [E. S-D., J. C.], and Max-Planck Institute for System Physiology, Rheinlanddamm 201, D-4600 Dortmund 1, Federal Republic of Germany [K. Z., G. H., E. D., H. A.]

Human glioma (U-118 MG, U-251 MG) and human colon carcinoma (HT-29) spheroids and monolayers were continuously exposed to amiloride under physiological Na+ and HCO3- conditions. Amiloride in concentrations of 0.1–0.2 mM inhibited growth, while 0.5 mM or higher induced disintegration of the glioma spheroids within 4–6 days. Growth retardation of the HT-29 spheroids was achieved at concentrations of 0.4–0.5 mM and total growth inhibition and disintegration were achieved at 1.0 mM. Monolayer cultures of glioma cells were also more sensitive to amiloride than those of colon carcinoma cells. The higher amiloride concentrations induced pyknotic nuclei mainly in the central areas of the spheroids where the extracellular pH (pHe) was low. The amiloride-sensitive glioma spheroids had lower pHe than the colon carcinoma spheroids. The intracellular pH (pHi), measured in monolayers, was higher (7.11–7.18) in glioma cells than in colon carcinoma cells (6.94). High concentrations of amiloride, 1.0 mM for 1 h in combination with low Na+ concentrations, caused a strong pHi decrease in glioma cells but only a slight decrease in the colon carcinoma cells. The pHi measurements in glioma monolayers were carried out after 2–6 days of continuous exposure to 0.1 mM amiloride at physiological levels of Na+ and HCO3- to simulate the conditions during growth inhibition. After several days this caused, when growth already was inhibited, an acidification of pHi. Parallel measurements with X-ray microanalysis showed an increase of intracellular sodium and a decrease of intracellular potassium in the gliomas, while no such changes were seen in the colon carcinoma cells under identical conditions. It is concluded that the two glioma cell lines were more sensitive to amiloride, both as monolayers and spheroids, than the corresponding cultures of the colon carcinoma cell line. The inhibition of proliferation by amiloride seemed not to have a clear connection to pHi regulation.

1 This work was financially supported by the Swedish National Board of Laboratory Animals 88-22, the Swedish National Board for Technical Development 86-05103P, the Swedish Cancer Society 1079-B90-01XA, Max-Planck-Gesellshaft, Munich, Germany, the Herrmann und Lilly Schilling Stiftung, Essen, Germany, and the BMFT, Bonn, Germany.

2 To whom requests for reprints should be addressed.

Received 3/30/90. Accepted 11/12/90.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
M. Hegde, J. Roscoe, P. Cala, and F. Gorin
Amiloride Kills Malignant Glioma Cells Independent of Its Inhibition of the Sodium-Hydrogen Exchanger
J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 67 - 74.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.